ArticleAnnals of nuclear medicine2019

A novel biomarker, active whole skeletal total lesion glycolysis (WS-TLG), as a quantitative method to measure bone metastatic activity in breast cancer patients.

Mitsuru Koizumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.